Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1984 1
1985 2
1986 1
1987 6
1989 1
1990 2
1991 1
1995 2
1996 1
1998 1
1999 1
2000 1
2001 1
2003 1
2004 2
2005 2
2006 3
2009 2
2010 1
2011 5
2012 11
2013 6
2014 2
2015 6
2016 8
2017 10
2018 12
2019 8
2020 11
2021 7
2022 2
2023 11
2024 16
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

129 results

Results by year

Filters applied: . Clear all
Page 1
[Sarcoidosis-lymphoma syndrome].
Partanen A, Pukkila S, Jantunen E. Partanen A, et al. Duodecim. 2016;132(7):661-5. Duodecim. 2016. PMID: 27188091 Review. Finnish.
Ixazomib, Lenalidomide, and Dexamethasone (IRD) Treatment with Cytogenetic Risk-Based Maintenance in Transplant-Eligible Myeloma: A Phase 2 Multicenter Study by the Nordic Myeloma Study Group.
Partanen A, Waage A, Peceliunas V, Schjesvold F, Anttila P, Säily M, Uttervall K, Putkonen M, Carlson K, Haukas E, Sankelo M, Szatkowski D, Hansson M, Marttila A, Svensson R, Axelsson P, Lauri B, Mikkola M, Karlsson C, Abelsson J, Ahlstrand E, Sikiö A, Klimkowska M, Matuzeviciene R, Fenstad MH, Ilveskero S, Pelliniemi TT, Nahi H, Silvennoinen R. Partanen A, et al. Cancers (Basel). 2024 Feb 29;16(5):1024. doi: 10.3390/cancers16051024. Cancers (Basel). 2024. PMID: 38473382 Free PMC article.
Magnetic Resonance-Guided Drug Delivery.
Mikhail AS, Partanen A, Yarmolenko P, Venkatesan AM, Wood BJ. Mikhail AS, et al. Among authors: partanen a. Magn Reson Imaging Clin N Am. 2015 Nov;23(4):643-55. doi: 10.1016/j.mric.2015.05.012. Epub 2015 Jul 9. Magn Reson Imaging Clin N Am. 2015. PMID: 26499281 Free PMC article. Review.
Climate Change, Summer Temperature, and Heat-Related Mortality in Finland: Multicohort Study with Projections for a Sustainable vs. Fossil-Fueled Future to 2050.
Kivimäki M, Batty GD, Pentti J, Suomi J, Nyberg ST, Merikanto J, Nordling K, Ervasti J, Suominen SB, Partanen AI, Stenholm S, Käyhkö J, Vahtera J. Kivimäki M, et al. Among authors: partanen ai. Environ Health Perspect. 2023 Dec;131(12):127020. doi: 10.1289/EHP12080. Epub 2023 Dec 27. Environ Health Perspect. 2023. PMID: 38150315 Free PMC article.
Ex vivo venetoclax sensitivity testing predicts treatment response in acute myeloid leukemia.
Kuusanmäki H, Kytölä S, Vänttinen I, Ruokoranta T, Ranta A, Huuhtanen J, Suvela M, Parsons A, Holopainen A, Partanen A, Kuusisto MEL, Koskela S, Räty R, Itälä-Remes M, Västrik I, Dufva O, Siitonen S, Porkka K, Wennerberg K, Heckman CA, Ettala P, Pyörälä M, Rimpiläinen J, Siitonen T, Kontro M. Kuusanmäki H, et al. Among authors: partanen a. Haematologica. 2023 Jul 1;108(7):1768-1781. doi: 10.3324/haematol.2022.281692. Haematologica. 2023. PMID: 36519325 Free PMC article.
Ex Vivo Venetoclax Sensitivity Predicts Clinical Response in Acute Myeloid Leukemia in the Prospective VenEx Trial.
Kytölä S, Vänttinen IM, Ruokoranta T, Partanen A, Holopainen A, Saad J, Kuusisto MEL, Koskela S, Räty RK, Itälä-Remes M, Västrik I, Suvela M, Parsons AO, Porkka K, Wennerberg K, Heckman CA, Jalkanen T, Huttunen T, Ettala P MD, Rimpiläinen J, Siitonen T, Pyörälä M, Kuusanmäki H, Kontro M. Kytölä S, et al. Among authors: partanen a. Blood. 2024 Oct 2:blood.2024024968. doi: 10.1182/blood.2024024968. Online ahead of print. Blood. 2024. PMID: 39357056
129 results